
Sign up to save your podcasts
Or


The pharmaceutical industry is pursuing what some consider to be the holy grail: developing and licensing the first drug that slows the body's natural aging process.
Writer: Jon Ungoed-Thomas
Producer: Casey Magloire
Host: Tomini Babs
Executive Producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
By The Observer4.6
1515 ratings
The pharmaceutical industry is pursuing what some consider to be the holy grail: developing and licensing the first drug that slows the body's natural aging process.
Writer: Jon Ungoed-Thomas
Producer: Casey Magloire
Host: Tomini Babs
Executive Producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.

848 Listeners

630 Listeners

993 Listeners

163 Listeners

258 Listeners

3 Listeners

26 Listeners

3,423 Listeners

73 Listeners

3,046 Listeners

976 Listeners

1,173 Listeners

820 Listeners

55 Listeners

47 Listeners

37 Listeners

487 Listeners

867 Listeners

200 Listeners

1 Listeners

15 Listeners

24 Listeners

53 Listeners

4 Listeners

169 Listeners

5 Listeners

11 Listeners

13 Listeners

81 Listeners

2 Listeners